e-learning
resources
Virtual 2021
07.09.2021
Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adverse reactions in the treatment of patients with non-tuberculous pulmonary mycobacteriosis.
E. Vladimirova (??????, Russian Federation), S. Evgeny (??????, Russian Federation), Z. Anna (??????, Russian Federation), D. Svetlana (??????, Russian Federation)
Source:
Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Session:
Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Session type:
E-poster
Number:
3085
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Vladimirova (??????, Russian Federation), S. Evgeny (??????, Russian Federation), Z. Anna (??????, Russian Federation), D. Svetlana (??????, Russian Federation). Adverse reactions in the treatment of patients with non-tuberculous pulmonary mycobacteriosis.. 3085
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Adverse reactions to the tuberculosis treatment
Source: Eur Respir J 2001; 18: Suppl. 33, 340s
Year: 2001
Adverse events during treatment of nontuberculous mycobacterial lung disease: do they really matter?
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018
Adverse events in the treatment of multidrug-resistant tuberculosis
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
The frequency of cases of hepatotoxic reactions in first diagnosed patients with pulmonary tuberculosis
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018
Clinical analysisof patients with pulmonary nontuberculous mycobacterial disease complicated with pneumothorax
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
Adverse effects of treatment in HIV-associated tuberculosis patients in Iran
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy
Source: Eur Respir J 2005; 25: 324-328
Year: 2005
Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients
Source: Eur Respir J 2006; 28: 1211-1215
Year: 2006
Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey
Source: Eur Respir J 2004; 24: Suppl. 48, 651s
Year: 2004
Cavitary formation in non-tuberculous mycobacterial infection is the significant risk for development to chronic pulmonary aspergillosis
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
CT patterns of pulmonary sarcoidosis are associated with prognosis and complication of chronic pulmonary aspergillosis or non-tuberculous mycobacteria
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Disseminated nontuberculous infections with Mycobacterium genavense during sarcoidosis
Source: Eur Respir Rev 2009; 18: 299-301
Year: 2009
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
Source: Eur Respir J 2011; 37: 865-872
Year: 2011
Treatment of pulmonary NTM infection: can it be done?
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007
Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
Adverse reactions of tuberculosis treatment in pacients with and without associated digestive disorders
Source: Eur Respir J 2003; 22: Suppl. 45, 522s
Year: 2003
Management of pulmonary nontuberculous mycobacteria disease
Source: Eur Respir Monogr 2018; 81: 222-237
Year: 2018
Monitoring of antituberculous drugs adverse events during the treatment of multidrug-resistant pulmonary tuberculosis
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Cure rates in nontuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept